Chitosan Interferon-γ Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses

The use of chitosan nanoparticles as carriers for expression plasmids represents a major improvement in gene expression technology. We demonstrated previously that treatment with chitosan interferon-γ (IFN-γ) plasmid deoxyribonucleic acid (DNA) nanoparticles (chitosan interferon-γ nanogene [CIN]) le...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kong, Xiaoyuan, Hellermann, Gary R, Zhang, Weidong, Jena, Prasanna, Kumar, Mukesh, Behera, Aruna, Behera, Sumita, Lockey, Richard, Mohapatra, Shyam S
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2008
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2868869/
https://ncbi.nlm.nih.gov/pubmed/20525130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1710-1492-4-3-95
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares